| scholarly article | Q13442814 |
| P50 | author | Lewis Kuller | Q88077314 |
| Jeffrey Samet | Q44867744 | ||
| Saitz R | Q67582554 | ||
| P2093 | author name string | Debbie M Cheng | |
| Matthew S Freiberg | |||
| Kevin L Kraemer | |||
| P2860 | cites work | Link between infection and atherosclerosis: who are the culprits: viruses, bacteria, both, or neither? | Q73341888 |
| “Mini-mental state” | Q25938989 | ||
| Evidence for association between hepatitis C virus seropositivity and coronary artery disease | Q27477947 | ||
| Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study | Q28293579 | ||
| Pathogenesis, natural history, treatment, and prevention of hepatitis C. | Q33841882 | ||
| Hepatitis C infection is associated with depressive symptoms in HIV-infected adults with alcohol problems | Q35069899 | ||
| Merging models of hepatitis C virus pathogenesis | Q36054701 | ||
| Screening for alcohol abuse using CAGE scores and likelihood ratios | Q37416011 | ||
| Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults : the Cardiovascular Health Study | Q37875347 | ||
| Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery | Q37882074 | ||
| Rates and Risk Factors for Condition-Specific Hospitalizations in HIV-Infected and Uninfected Women | Q39668656 | ||
| Comorbid medical and psychiatric conditions and substance abuse in HCV infected persons on dialysis | Q40345798 | ||
| Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group | Q43036483 | ||
| Association between hepatitis C virus core protein and carotid atherosclerosis | Q43041764 | ||
| Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy | Q43041935 | ||
| Hepatitis C virus and atherosclerosis in patients with type 2 diabetes | Q43049310 | ||
| Hepatitis C virus seropositivity, but not hepatitis B virus carrier or seropositivity, associated with increased pulse wave velocity | Q43417279 | ||
| An objective case definition of lipodystrophy in HIV-infected adults: a case-control study | Q44350196 | ||
| Combination antiretroviral therapy and the risk of myocardial infarction | Q44662157 | ||
| Lack of any association between persistent hepatitis B or C virus infection and coronary artery disease | Q45452533 | ||
| Hepatitis B and C virus infection and the risk of atherosclerosis in a general population | Q45641514 | ||
| Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening | Q45733968 | ||
| Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States | Q45740183 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| hepatitis C | Q154869 | ||
| P304 | page(s) | 193-197 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | AIDS | Q4651863 |
| P1476 | title | The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals | |
| P478 | volume | 21 |
| Q36401521 | A Cross-sectional Study of the Association Between Chronic Hepatitis C Virus Infection and Subclinical Coronary Atherosclerosis Among Participants in the Multicenter AIDS Cohort Study |
| Q48856213 | Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era. |
| Q36922487 | Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: the fat redistribution and metabolic change in HIV infection (FRAM) study |
| Q27490429 | Association of Hepatitis C Virus Seropositivity With Inflammatory Markers and Heart Failure in Persons With Coronary Heart Disease: Data From the Heart and Soul Study |
| Q33761167 | Association of hepatitis C virus and HIV infection with subclinical atherosclerosis in the women's interagency HIV study |
| Q37625493 | Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems |
| Q38695606 | Chronic hepatitis C virus infection, a new cardiovascular risk factor? |
| Q34171033 | Does hepatitis C virus infection increase risk for stroke? A population-based cohort study |
| Q34038709 | Evaluation of endothelial function and subclinical atherosclerosis in association with hepatitis C virus in HIV-infected patients: a cross-sectional study |
| Q37386676 | Focus on the heart: alcohol consumption, HIV infection, and cardiovascular disease |
| Q36956654 | HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox". |
| Q35611619 | HIV status and the risk of ischemic stroke among men. |
| Q37011927 | HIV/AIDS, comorbidity, and alcohol: can we make a difference? |
| Q38787354 | HIV/HCV coinfection and the risk of cardiovascular disease: A meta-analysis. |
| Q33435099 | Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study |
| Q40989818 | Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients |
| Q31127335 | Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study |
| Q36496736 | Impact of immunodepression and moderate alcohol consumption on coronary and other arterial disease events in an 11-year cohort of HIV-infected patients on antiretroviral therapy |
| Q36957752 | Inflammation, immune activation, and cardiovascular disease in HIV. |
| Q42288046 | Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan. |
| Q34813144 | Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era |
| Q38832560 | Neurologic Complications in Treated HIV-1 Infection |
| Q37038775 | Pathophysiology and management of cardiovascular disease in patients with HIV |
| Q45867274 | Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US). |
| Q47169604 | Risk of Cardiovascular Disease Due to Chronic Hepatitis C Infection: A Review. |
| Q38261508 | Risk of coronary heart disease in patients with HIV infection |
| Q36419552 | Short communication: risk of elevated total cholesterol/high-density lipoprotein cholesterol ratio after antiretroviral therapy in HIV/hepatitis C virus patients. |
| Q37096897 | The association between the receipt of lipid lowering therapy and HIV status among veterans who met NCEP/ATP III criteria for the receipt of lipid lowering medication |
| Q35174850 | The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C |
| Q36914988 | Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy |
Search more.